Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Morris

Showing results (161-170 of 207) with videos related to

Pageof 21
Sort By:
Frontiers in Physiology|August 14, 2025
Pulse rate variability is not the same as heart rate variability: findings from a large, diverse clinical population studyAllen B Kantrowitz, Kfir Ben-David, Michael Morris, et al.
Indian Pediatrics|September 13, 2023
Postoperative Outcomes, and Growth and Brain Injury Outcomes in Spontaneous Intestinal Perforation vs Surgical Necrotizing Enterocolitis in Preterm InfantsParvesh Mohan Garg, Katheryn Lett, Md Abu Yusuf Ansari, et al.
Radiology|August 20, 2008
Incidence of nephrogenic systemic fibrosis at two large medical centersMartin R Prince, Honglei Zhang, Michael Morris, et al.
Mucosal Immunology|September 16, 2023
Alpha-tocopherylquinone-mediated activation of the Aryl Hydrocarbon Receptor regulates the production of inflammation-inducing cytokines and ameliorates intestinal inflammationKushal Saha, Ashwinkumar Subramenium Ganapathy, Alexandra Wang, et al.
Cancer Immunology, Immunotherapy : CII|July 11, 2007
A polyvalent vaccine for high-risk prostate patients: "are more antigens better?"Susan F Slovin, Govind Ragupathi, Celina Fernandez, et al.
Transboundary and Emerging Diseases|December 18, 2025
Diversity of Ticks in the Caribbean Region and Detection of Their Pathogens Using BioMark TechnologyRoxanne A Charles, Emmanuel Albina, Mathilde Gondard, et al.
Urologic Oncology|August 6, 2011
A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancerJianqing Lin, Marianna Zahurak, Tomasz M Beer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2012
Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401William Kevin Kelly, Susan Halabi, Michael Carducci, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2004
PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancerPat B Zanzonico, Ronald Finn, Keith S Pentlow, et al.
Sports Medicine - Open|June 12, 2026
Pulse Rate Variability Is Not the Same as Heart Rate Variability: Implications for Sports Performance and Injury PreventionKfir Ben-David, Allen B Kantrowitz, Michael Morris, et al.
Pageof 21

Showing results (161-170 of 207) with videos related to

Sort By:
Pageof 21
Frontiers in Physiology|August 14, 2025
Pulse rate variability is not the same as heart rate variability: findings from a large, diverse clinical population studyAllen B Kantrowitz, Kfir Ben-David, Michael Morris, et al.
Indian Pediatrics|September 13, 2023
Postoperative Outcomes, and Growth and Brain Injury Outcomes in Spontaneous Intestinal Perforation vs Surgical Necrotizing Enterocolitis in Preterm InfantsParvesh Mohan Garg, Katheryn Lett, Md Abu Yusuf Ansari, et al.
Radiology|August 20, 2008
Incidence of nephrogenic systemic fibrosis at two large medical centersMartin R Prince, Honglei Zhang, Michael Morris, et al.
Mucosal Immunology|September 16, 2023
Alpha-tocopherylquinone-mediated activation of the Aryl Hydrocarbon Receptor regulates the production of inflammation-inducing cytokines and ameliorates intestinal inflammationKushal Saha, Ashwinkumar Subramenium Ganapathy, Alexandra Wang, et al.
Cancer Immunology, Immunotherapy : CII|July 11, 2007
A polyvalent vaccine for high-risk prostate patients: "are more antigens better?"Susan F Slovin, Govind Ragupathi, Celina Fernandez, et al.
Transboundary and Emerging Diseases|December 18, 2025
Diversity of Ticks in the Caribbean Region and Detection of Their Pathogens Using BioMark TechnologyRoxanne A Charles, Emmanuel Albina, Mathilde Gondard, et al.
Urologic Oncology|August 6, 2011
A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancerJianqing Lin, Marianna Zahurak, Tomasz M Beer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2012
Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401William Kevin Kelly, Susan Halabi, Michael Carducci, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2004
PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancerPat B Zanzonico, Ronald Finn, Keith S Pentlow, et al.
Sports Medicine - Open|June 12, 2026
Pulse Rate Variability Is Not the Same as Heart Rate Variability: Implications for Sports Performance and Injury PreventionKfir Ben-David, Allen B Kantrowitz, Michael Morris, et al.
Pageof 21